Agile Therapeutics (AGRX) Financials

$1.51

$0.00 (0.00%)

As on 26-Aug-2024 15:20EDT

Market cap

$10 Mln

Revenue (TTM)

$22 Mln

P/E Ratio

--

P/B Ratio

1.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	21.57	19.59	10.88	4.10	0.75	--
Cost of Revenue	7.84	8.98	6.84	10.72	0.28	0.16
Gross Profit	13.72	10.62	4.05	-6.62	0.47	-0.16
Operating Expenses	27.28	30.50	45.48	64.39	49.52	18.86
Operating Profit (EBIT)	-13.56	-19.88	-41.43	-71.01	-49.05	-18.86
Other Income	--	--	--	--	0.31	0.25
Profit before Tax	-15.86	-14.47	-30.09	-74.89	-51.85	-18.61
Provision for Tax	0.39	1.42	-4.68	1.69	2.83	-0.16
Profit after Tax (Net Income)	-15.86	-14.47	-25.41	-76.59	-54.69	-18.44
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-0.80	--	--	-74.89	-51.85	-18.61

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	-21.91	-16.32	-5.55	9.27	49.33	45.75
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	10.65	5.80	6.40	0.78	16.38	1.99
Current Liabilities	26.23	20.78	13.39	29.28	7.35	3.80
Total Liabilities	41.19	10.26	14.24	39.33	73.06	49.54

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	0.52	0.73	2.88	15.41	16.28	14.22
Current Assets	14.44	9.53	11.36	23.93	56.79	35.32
Total Assets	41.19	10.26	14.24	39.33	73.06	49.54
Total Debt*	0.29	2.17	2.21	17.79	16.52	0.17
Net Current Assets	-11.79	-11.25	-2.03	-5.35	49.43	31.52

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-9.58	-35.95	-65.20	-47.31	-15.69
Cash Flow from Investing Activities	--	--	--	39.46	-40.69	-0.10
Cash from Financing Activities	--	6.89	22.18	30.42	67.99	42.42
Net Cash Inflow / Outflow	--	--	--	--	-20.02	26.63

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-3.23	-4.88	-30.81	-1,298.05	-1,251.40	-589.23
Cash EPS ($)	--	-4.75	-28.95	-1,260.37	-1,245.08	-584.03
Adjusted Book Value ($)	--	--	--	157.14	1,128.79	1,461.50
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.23	-43.59	-1,105.12	-1,082.63	-501.25
Free Cash Flow per Share ($)	--	-3.23	-43.75	-1,109.68	-1,090.71	-504.38

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	165.50	-214.19	-164.86	-97.86	-55.81
ROE (%)	--	132.32	-1,364.04	-261.39	-115.04	-55.96
ROA (%)	-45.92	-118.10	-94.87	-136.28	-89.21	-51.28
EBIT Margin (%)	-33.51	-103.46	-380.69	-1,637.48	-6,507.88	--
Net Margin (%)	-73.52	-73.83	-233.48	-1,867.47	-5,168.81	-7,318.65
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	32.21	0.80	1.65	4.48	--	--
EBIT Growth (%)	72.24	51.08	38.30	-37.77	-159.58	-2.55
Net Profit Growth (%)	62.90	43.08	66.82	-40.04	-196.51	6.75
EPS Growth (%)	93.78	0.84	0.98	-0.04	-1.12	0.49
Book Value Growth (%)	53.34	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-0.40	-0.01	0.00	0.00	0.00
Price / Book Value	1.79	-0.35	-0.03	0.00	0.00	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.11	-0.27	0.07	0.02	0.78	1.84
Close Price ($)	1.41	1.95	11.35	976.20	5,740.00	5,000.00
High Price ($)	3.40	16.00	1,067.00	7,540.00	9,530.40	5,940.00
Low Price ($)	--	1.65	8.75	940.40	2,700.00	700.00
Market Cap ($ Cr)	10.43	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	-0.13	-0.40	1.92	0.33	0.00
Short term debt to equity ratio	-0.01	-0.13	-0.37	1.85	0.01	0.00
Current Ratio	0.55	0.46	0.85	0.82	7.72	9.31
Quick Ratio	0.33	0.33	0.75	0.78	7.72	--
Interest Coverage	-18.08	-14.28	-13.23	-17.16	-15.68	-47.18

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	21.10	17.31	31.03	37.38	115.49	--
Asset Turnover	0.62	1.60	0.41	0.07	0.01	--
Receivable days	--	63.09	82.39	106.79	421.82	--
Inventory Days	--	82.79	61.39	16.46	0.00	--
Payable days	--	352.07	439.22	214.25	3,682.29	4,523.05
Cash Conversion Cycle	--	-206.19	-295.45	-91.00	-3,260.47	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.